| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-09 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
1e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-07 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.25 |
1e-05 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |